1 |
(r)-(1-(4-fluorophenyl)-6-((1-methyl-1h-pyrazol-4-yl)sulfonyl)-4,4a,5,6,7,8-hexahydro-1h-pyrazolo[3,4-g]isoquinolin-4a-yl)(4-(trifluoromethyl)pyridin-2-yl)methanone |
Pyrazole |
- |
- |
- |
075 1件: 75 💬 |
2 |
(r)-(1-(4-fluorophenyl)-6-((1-methyl-1h-pyrazol-4-yl)sulfonyl)4,4a,5,6,7,8-hexahydro-1h-pyrazolo[3,4-g]isoquinolin-4a-yl)(4(trifluoromethyl)pyridin-2-yl)methanone |
Pyrazole |
- |
- |
- |
075 1件: 75 💬 |
3 |
17beta-hydroxy-11beta-(4-dimethylaminophenyl)17a-(prop-1-ynyl)estra-4,9-dien-3-one |
- |
- |
- |
- |
075 1件: 75 💬 |
4 |
17ß-hydroxy-11ß-(4-dimethylaminophenyl)17a-(prop-1-ynyl)estra-4,9-dien-3-one |
- |
- |
- |
- |
075 1件: 75 💬 |
5 |
18f-dopa |
- |
- |
- |
- |
006 3件: 6 , 17, 75 💬 |
6 |
1h-pyrazol |
Pyrazole |
- |
- |
- |
028 3件: 28, 46, 75 💬 |
7 |
2s,4r-(-)-ketoconazole |
Ketoconazole |
1件: D00351 D00351 💬 |
CYP17A1 1件: CYP17A1 💬 |
Cortisol synthesis and secretion 6件: Cortisol synthesis and secretion, Cushing syndrome, Metabolic pathways, Ovarian steroidogenesis, Prolactin signaling pathway, Steroid hormone biosynthesis |
075 1件: 75 💬 |
8 |
2s,4r-(-)-ketoconazole, levoketoconazole |
Ketoconazole |
2件: D00351 D00351, D10950 D10950 💬 |
CYP17A1 1件: CYP17A1 💬 |
Cortisol synthesis and secretion 6件: Cortisol synthesis and secretion, Cushing syndrome, Metabolic pathways, Ovarian steroidogenesis, Prolactin signaling pathway, Steroid hormone biosynthesis |
075 1件: 75 💬 |
9 |
Abiraterone |
Abiraterone |
1件: D09701 D09701 💬 |
- |
- |
075 2件: 75, 81 💬 |
10 |
Abiraterone acetate |
Abiraterone |
1件: D09701 D09701 💬 |
- |
- |
075 2件: 75, 81 💬 |
11 |
Acetate |
Acetate |
- |
- |
- |
001 43件: 1 , 2 , 6 , 10, 13, 35, 40, 46, 49, 51, 60, 64, 67, 70, 71, 73, 75, 76, 78, 79, 81, 83, 85, 86, 88, 90, 96, 97, 113, 145, 156, 162, 171, 206, 222, 224, 225, 227, 235, 265, 288, 298, 299 💬 |
12 |
Acthrel |
- |
- |
- |
- |
075 1件: 75 💬 |
13 |
Atr-101 |
- |
- |
- |
- |
075 2件: 75, 81 💬 |
14 |
Azd4017 |
- |
- |
- |
- |
075 1件: 75 💬 |
15 |
Azd4017 and prednisolone |
Prednisolone |
8件: D00472 D00472, D00980 D00980, D00981 D00981, D00982 D00982, D01239 D01239, D01998 D01998, D02156 D02156, D03301 D03301 💬 |
NR3C1 1件: NR3C1 💬 |
Neuroactive ligand-receptor interaction 1件: Neuroactive ligand-receptor interaction |
075 1件: 75 💬 |
16 |
Bexarotene |
Bexarotene |
1件: D03106 D03106 💬 |
RXRA 3件: RXRA, RXRB, RXRG 💬 |
Adipocytokine signaling pathway 15件: Adipocytokine signaling pathway, Bile secretion, Gastric cancer, Hepatitis C, Non-alcoholic fatty liver disease, Non-small cell lung cancer, PI3K-Akt signaling pathway, PPAR signaling pathway, Parathyroid hormone synthesis, secretion and action, Pathways in cancer, Small cell lung cancer, Th17 cell differentiation, Thyroid cancer, Thyroid hormone signaling pathway, Transcriptional misregulation in cancer |
013 2件: 13, 75 💬 |
17 |
Cabergoline |
Cabergoline |
1件: D00987 D00987 💬 |
DRD2 2件: DRD2, PRL 💬 |
Alcoholism 12件: Alcoholism, Cocaine addiction, Cytokine-cytokine receptor interaction, Dopaminergic synapse, Gap junction, JAK-STAT signaling pathway, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway, Parkinson disease, Prolactin signaling pathway, Rap1 signaling pathway, cAMP signaling pathway |
006 3件: 6 , 74, 75 💬 |
18 |
Cabergoline teva |
Cabergoline |
1件: D00987 D00987 💬 |
DRD2 2件: DRD2, PRL 💬 |
Alcoholism 12件: Alcoholism, Cocaine addiction, Cytokine-cytokine receptor interaction, Dopaminergic synapse, Gap junction, JAK-STAT signaling pathway, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway, Parkinson disease, Prolactin signaling pathway, Rap1 signaling pathway, cAMP signaling pathway |
075 1件: 75 💬 |
19 |
Calcium |
Calcium |
- |
- |
- |
006 27件: 6 , 13, 19, 46, 49, 51, 53, 56, 68, 75, 79, 84, 93, 94, 95, 96, 97, 186, 214, 215, 222, 224, 235, 265, 274, 298, 299 💬 |
20 |
Calcium carbonate |
Calcium |
2件: D00932 D00932, D10802 D10802 💬 |
- |
- |
013 8件: 13, 19, 46, 53, 75, 96, 235, 299 💬 |
21 |
Carbonate |
Carbonate ion |
- |
- |
- |
002 12件: 2 , 13, 17, 18, 19, 46, 53, 75, 96, 127, 235, 299 💬 |
22 |
Ci-984 |
- |
- |
- |
- |
075 1件: 75 💬 |
23 |
Cialis - 20 mg 2 compresse rivestite con film in blister uso orale |
- |
- |
- |
- |
075 1件: 75 💬 |
24 |
Cor-003 |
- |
- |
- |
- |
075 1件: 75 💬 |
25 |
Cort125134 |
Relacorilant |
1件: D11336 D11336 💬 |
NR3C1 1件: NR3C1 💬 |
Neuroactive ligand-receptor interaction 1件: Neuroactive ligand-receptor interaction |
075 1件: 75 💬 |
26 |
Corticotropin |
Corticotropin |
1件: D00146 D00146 💬 |
MC2R 1件: MC2R 💬 |
Aldosterone synthesis and secretion 5件: Aldosterone synthesis and secretion, Cortisol synthesis and secretion, Cushing syndrome, Neuroactive ligand-receptor interaction, cAMP signaling pathway |
002 7件: 2 , 13, 46, 75, 78, 84, 222 💬 |
27 |
Corticotropin-releasing hormone |
Corticorelin |
2件: D00146 D00146, D03905 D03905 💬 |
CRHR1 3件: CRHR1, CRHR2, MC2R 💬 |
Aldosterone synthesis and secretion 6件: Aldosterone synthesis and secretion, Cortisol synthesis and secretion, Cushing syndrome, Long-term depression, Neuroactive ligand-receptor interaction, cAMP signaling pathway |
075 1件: 75 💬 |
28 |
Cushing's syndrome confirmation |
- |
- |
- |
- |
075 1件: 75 💬 |
29 |
Cyclo ((diaminoethyl-carbamate)hypro-phg-(d) trp-ly di-aspartate |
- |
- |
- |
- |
075 1件: 75 💬 |
30 |
Cyclo ((diaminoethyl-carbamate)hypro-phg-(d)trp-ly di-aspartate |
- |
- |
- |
- |
075 1件: 75 💬 |
31 |
Cyclo((diaminoethyl-carbamate)hypro-phg-(d)trp-lys-tyr(bzl)-phe) di-aspartate |
- |
- |
- |
- |
075 1件: 75 💬 |
32 |
Cyclo(diaminoethyl-carbamate)hypro-phg-(d)trp-lys-tyr(bzl)-phe) |
- |
- |
- |
- |
075 1件: 75 💬 |
33 |
Ddavp |
Desmopressin |
2件: D00291 D00291, D02235 D02235 💬 |
AVPR2 2件: AVPR2, F8 💬 |
Complement and coagulation cascades 4件: Complement and coagulation cascades, Neuroactive ligand-receptor interaction, Phospholipase D signaling pathway, Vasopressin-regulated water reabsorption |
075 2件: 75, 288 💬 |
34 |
Device: continuous glucose monitoring |
Dextrose, unspecified form |
- |
- |
- |
075 2件: 75, 299 💬 |
35 |
Device: ipc |
- |
- |
- |
- |
075 1件: 75 💬 |
36 |
Dexamethasone |
Dexamethasone |
9件: D00292 D00292, D00975 D00975, D01510 D01510, D01615 D01615, D01632 D01632, D01948 D01948, D02174 D02174, D02591 D02591, D02592 D02592 💬 |
NR3C1 1件: NR3C1 💬 |
Neuroactive ligand-receptor interaction 1件: Neuroactive ligand-receptor interaction |
013 25件: 13, 14, 16, 28, 35, 46, 53, 63, 64, 65, 70, 74, 75, 81, 83, 84, 90, 96, 97, 162, 222, 235, 283, 296, 299 💬 |
37 |
Diagnostic test: 24-hour urine test |
- |
- |
- |
- |
075 1件: 75 💬 |
38 |
Diagnostic test: blood test |
- |
- |
- |
- |
075 1件: 75 💬 |
39 |
Diagnostic test: ct scan |
- |
- |
- |
- |
075 1件: 75 💬 |
40 |
Diagnostic test: dexamethasone test |
Dexamethasone |
9件: D00292 D00292, D00975 D00975, D01510 D01510, D01615 D01615, D01632 D01632, D01948 D01948, D02174 D02174, D02591 D02591, D02592 D02592 💬 |
NR3C1 1件: NR3C1 💬 |
Neuroactive ligand-receptor interaction 1件: Neuroactive ligand-receptor interaction |
075 1件: 75 💬 |
41 |
Diagnostic test: mri |
- |
- |
- |
- |
075 1件: 75 💬 |
42 |
Diagnostic test: saliva swab |
- |
- |
- |
- |
075 1件: 75 💬 |
43 |
Dostinex |
- |
- |
- |
- |
075 1件: 75 💬 |
44 |
Dotatate |
Dotatate |
- |
- |
- |
041 3件: 41, 75, 84 💬 |
45 |
Eplerenone |
Eplerenone |
1件: D01115 D01115 💬 |
NR3C2 1件: NR3C2 💬 |
Aldosterone-regulated sodium reabsorption 1件: Aldosterone-regulated sodium reabsorption |
075 4件: 75, 113, 210, 215 💬 |
46 |
Gefitinib |
Gefitinib |
1件: D01977 D01977 💬 |
EGFR 1件: EGFR 💬 |
Adherens junction 46件: Adherens junction, Bladder cancer, Breast cancer, Calcium signaling pathway, Central carbon metabolism in cancer, Choline metabolism in cancer, Colorectal cancer, Coronavirus disease - COVID-19, Cushing syndrome, EGFR tyrosine kinase inhibitor resistance, Endocrine resistance, Endocytosis, Endometrial cancer, Epithelial cell signaling in Helicobacter pylori infection, ErbB signaling pathway, Estrogen signaling pathway, Focal adhesion, FoxO signaling pathway, Gap junction, Gastric cancer, Glioma, GnRH signaling pathway, HIF-1 signaling pathway, Hepatitis C, Hepatocellular carcinoma, Human cytomegalovirus infection, Human papillomavirus infection, JAK-STAT signaling pathway, MAPK signaling pathway, Melanoma, MicroRNAs in cancer, Non-small cell lung cancer, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Parathyroid hormone synthesis, secretion and action, Pathways in cancer, Phospholipase D signaling pathway, Prostate cancer, Proteoglycans in cancer, Rap1 signaling pathway, Ras signaling pathway, Regulation of actin cytoskeleton, Relaxin signaling pathway, Shigellosis |
075 1件: 75 💬 |
47 |
Genotropin 12mg |
- |
- |
- |
- |
074 3件: 74, 75, 78 💬 |
48 |
Genotropin 5.3mg |
- |
- |
- |
- |
074 3件: 74, 75, 78 💬 |
49 |
Genotropin miniqu |
- |
- |
- |
- |
074 3件: 74, 75, 78 💬 |
50 |
Genotropin miniquick 0.2mg |
- |
- |
- |
- |
074 3件: 74, 75, 78 💬 |
51 |
Genotropin miniquick 0.4mg |
- |
- |
- |
- |
074 3件: 74, 75, 78 💬 |
52 |
Genotropin miniquick 0.6mg |
- |
- |
- |
- |
074 3件: 74, 75, 78 💬 |
53 |
Genotropin miniquick 0.8mg |
- |
- |
- |
- |
074 3件: 74, 75, 78 💬 |
54 |
Genotropin miniquick 1.0mg |
- |
- |
- |
- |
074 3件: 74, 75, 78 💬 |
55 |
Genotropin miniquick 1.2mg |
- |
- |
- |
- |
074 3件: 74, 75, 78 💬 |
56 |
Glucocorticoids |
- |
- |
- |
- |
040 8件: 40, 41, 43, 44, 60, 62, 75, 300 💬 |
57 |
Glucophage (metformin) |
Metformin |
2件: D00944 D00944, D04966 D04966 💬 |
PRKAA1 2件: PRKAA1, PRKAA2 💬 |
AMPK signaling pathway 19件: AMPK signaling pathway, Adipocytokine signaling pathway, Apelin signaling pathway, Autophagy - animal, Circadian rhythm, Fluid shear stress and atherosclerosis, FoxO signaling pathway, Glucagon signaling pathway, Hypertrophic cardiomyopathy, Insulin resistance, Insulin signaling pathway, Longevity regulating pathway, Longevity regulating pathway - multiple species, Non-alcoholic fatty liver disease, Oxytocin signaling pathway, PI3K-Akt signaling pathway, Thermogenesis, Tight junction, mTOR signaling pathway |
046 2件: 46, 75 💬 |
58 |
Glucose |
Dextrose, unspecified form |
- |
- |
- |
002 15件: 2 , 6 , 13, 49, 50, 65, 75, 86, 88, 96, 160, 195, 254, 257, 299 💬 |
59 |
Hra052015 |
- |
- |
- |
- |
075 1件: 75 💬 |
60 |
Hra052015 (mifepristone) |
Mifepristone |
1件: D00585 D00585 💬 |
NR3C1 2件: NR3C1, PGR 💬 |
Breast cancer 5件: Breast cancer, Estrogen signaling pathway, Neuroactive ligand-receptor interaction, Oocyte meiosis, Progesterone-mediated oocyte maturation |
075 1件: 75 💬 |
61 |
Hydrocortisone |
Hydrocortisone |
1件: D00088 D00088 💬 |
NR3C1 1件: NR3C1 💬 |
Neuroactive ligand-receptor interaction 1件: Neuroactive ligand-receptor interaction |
006 9件: 6 , 46, 53, 75, 78, 81, 83, 97, 299 💬 |
62 |
Hypro |
- |
- |
- |
- |
075 1件: 75 💬 |
63 |
Insulin |
- |
- |
- |
- |
013 5件: 13, 46, 75, 78, 299 💬 |
64 |
Ketoconazole |
Ketoconazole |
1件: D00351 D00351 💬 |
CYP17A1 1件: CYP17A1 💬 |
Cortisol synthesis and secretion 6件: Cortisol synthesis and secretion, Cushing syndrome, Metabolic pathways, Ovarian steroidogenesis, Prolactin signaling pathway, Steroid hormone biosynthesis |
008 3件: 8 , 13, 75 💬 |
65 |
L0006cp03a |
- |
- |
- |
- |
075 1件: 75 💬 |
66 |
La |
- |
- |
- |
- |
006 5件: 6 , 13, 75, 76, 222 💬 |
67 |
Lapatinib |
Lapatinib |
2件: D04024 D04024, D08108 D08108 💬 |
EGFR 2件: EGFR, ERBB2 💬 |
Adherens junction 48件: Adherens junction, Bladder cancer, Breast cancer, Calcium signaling pathway, Central carbon metabolism in cancer, Choline metabolism in cancer, Colorectal cancer, Coronavirus disease - COVID-19, Cushing syndrome, EGFR tyrosine kinase inhibitor resistance, Endocrine resistance, Endocytosis, Endometrial cancer, Epithelial cell signaling in Helicobacter pylori infection, ErbB signaling pathway, Estrogen signaling pathway, Focal adhesion, FoxO signaling pathway, Gap junction, Gastric cancer, Glioma, GnRH signaling pathway, HIF-1 signaling pathway, Hepatitis C, Hepatocellular carcinoma, Human cytomegalovirus infection, Human papillomavirus infection, JAK-STAT signaling pathway, MAPK signaling pathway, Melanoma, MicroRNAs in cancer, Non-small cell lung cancer, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Parathyroid hormone synthesis, secretion and action, Pathways in cancer, Phospholipase D signaling pathway, Platinum drug resistance, Prostate cancer, Proteoglycans in cancer, Rap1 signaling pathway, Ras signaling pathway, Regulation of actin cytoskeleton, Relaxin signaling pathway, Shigellosis, Tight junction |
034 3件: 34, 74, 75 💬 |
68 |
Lci699 |
- |
- |
- |
- |
075 1件: 75 💬 |
69 |
Lci699, 1 mg |
- |
- |
- |
- |
075 1件: 75 💬 |
70 |
Lci699, 10 mg |
- |
- |
- |
- |
075 1件: 75 💬 |
71 |
Lci699, 20 mg |
- |
- |
- |
- |
075 1件: 75 💬 |
72 |
Lci699, 5 mg |
- |
- |
- |
- |
075 1件: 75 💬 |
73 |
Levoketoconazole |
Levoketoconazole |
1件: D10950 D10950 💬 |
- |
- |
075 1件: 75 💬 |
74 |
Levoketozonazole |
- |
- |
- |
- |
075 1件: 75 💬 |
75 |
Liqourice |
- |
- |
- |
- |
075 1件: 75 💬 |
76 |
Liraglutide |
Liraglutide |
1件: D06404 D06404 💬 |
GLP1R 1件: GLP1R 💬 |
Insulin secretion 3件: Insulin secretion, Neuroactive ligand-receptor interaction, cAMP signaling pathway |
006 3件: 6 , 75, 193 💬 |
77 |
Lmwh/rivaroxaban |
Rivaroxaban |
1件: D07086 D07086 💬 |
F10 1件: F10 💬 |
Complement and coagulation cascades 1件: Complement and coagulation cascades |
075 1件: 75 💬 |
78 |
Matyrapone |
- |
- |
- |
- |
075 1件: 75 💬 |
79 |
Metformin |
Metformin |
2件: D00944 D00944, D04966 D04966 💬 |
PRKAA1 2件: PRKAA1, PRKAA2 💬 |
AMPK signaling pathway 19件: AMPK signaling pathway, Adipocytokine signaling pathway, Apelin signaling pathway, Autophagy - animal, Circadian rhythm, Fluid shear stress and atherosclerosis, FoxO signaling pathway, Glucagon signaling pathway, Hypertrophic cardiomyopathy, Insulin resistance, Insulin signaling pathway, Longevity regulating pathway, Longevity regulating pathway - multiple species, Non-alcoholic fatty liver disease, Oxytocin signaling pathway, PI3K-Akt signaling pathway, Thermogenesis, Tight junction, mTOR signaling pathway |
002 21件: 2 , 6 , 13, 46, 49, 60, 67, 75, 77, 81, 86, 113, 127, 158, 206, 225, 233, 265, 285, 299, 301 💬 |
80 |
Methionine |
Methionine |
2件: D00019 D00019, D04983 D04983 💬 |
- |
- |
034 7件: 34, 75, 84, 93, 229, 298, 300 💬 |
81 |
Metopirone |
- |
- |
- |
- |
075 1件: 75 💬 |
82 |
Metopirone 250 mg capsules |
- |
- |
- |
- |
075 1件: 75 💬 |
83 |
Metopirone 250 mg capsules/cormeto |
- |
- |
- |
- |
075 1件: 75 💬 |
84 |
Metyrapone |
Metyrapone |
2件: D00410 D00410, D05019 D05019 💬 |
CYP11B1 1件: CYP11B1 💬 |
Cortisol synthesis and secretion 4件: Cortisol synthesis and secretion, Cushing syndrome, Metabolic pathways, Steroid hormone biosynthesis |
075 2件: 75, 193 💬 |
85 |
Mifedren |
- |
- |
- |
- |
075 1件: 75 💬 |
86 |
Mifepristone |
Mifepristone |
1件: D00585 D00585 💬 |
NR3C1 2件: NR3C1, PGR 💬 |
Breast cancer 5件: Breast cancer, Estrogen signaling pathway, Neuroactive ligand-receptor interaction, Oocyte meiosis, Progesterone-mediated oocyte maturation |
075 1件: 75 💬 |
87 |
Nevanimibe |
Nevanimibe |
1件: D11300 D11300 💬 |
- |
- |
075 2件: 75, 81 💬 |
88 |
Nevanimibe hydrochloride |
Nevanimibe |
1件: D11300 D11300 💬 |
- |
- |
075 2件: 75, 81 💬 |
89 |
Nizoral |
- |
- |
- |
- |
075 1件: 75 💬 |
90 |
Octreotide |
Octreotide |
2件: D00442 D00442, D06495 D06495 💬 |
SSTR2 1件: SSTR2 💬 |
Gastric acid secretion 4件: Gastric acid secretion, Growth hormone synthesis, secretion and action, Neuroactive ligand-receptor interaction, cAMP signaling pathway |
067 7件: 67, 75, 84, 85, 89, 193, 227 💬 |
91 |
Orocal |
- |
- |
- |
- |
075 1件: 75 💬 |
92 |
Osilodrostat |
Osilodrostat |
1件: D11061 D11061 💬 |
CYP11B2 1件: CYP11B2 💬 |
Aldosterone synthesis and secretion 3件: Aldosterone synthesis and secretion, Metabolic pathways, Steroid hormone biosynthesis |
075 1件: 75 💬 |
93 |
Osilodrostat 10mg |
Osilodrostat |
1件: D11061 D11061 💬 |
CYP11B2 1件: CYP11B2 💬 |
Aldosterone synthesis and secretion 3件: Aldosterone synthesis and secretion, Metabolic pathways, Steroid hormone biosynthesis |
075 1件: 75 💬 |
94 |
Osilodrostat 1mg |
Osilodrostat |
1件: D11061 D11061 💬 |
CYP11B2 1件: CYP11B2 💬 |
Aldosterone synthesis and secretion 3件: Aldosterone synthesis and secretion, Metabolic pathways, Steroid hormone biosynthesis |
075 1件: 75 💬 |
95 |
Osilodrostat 20mg |
Osilodrostat |
1件: D11061 D11061 💬 |
CYP11B2 1件: CYP11B2 💬 |
Aldosterone synthesis and secretion 3件: Aldosterone synthesis and secretion, Metabolic pathways, Steroid hormone biosynthesis |
075 1件: 75 💬 |
96 |
Osilodrostat 5mg |
Osilodrostat |
1件: D11061 D11061 💬 |
CYP11B2 1件: CYP11B2 💬 |
Aldosterone synthesis and secretion 3件: Aldosterone synthesis and secretion, Metabolic pathways, Steroid hormone biosynthesis |
075 1件: 75 💬 |
97 |
Ossein hydroxyapatite |
- |
- |
- |
- |
075 1件: 75 💬 |
98 |
Osteopor |
- |
- |
- |
- |
075 1件: 75 💬 |
99 |
Other: [11c]-methionine pet/mri |
Methionine |
2件: D00019 D00019, D04983 D04983 💬 |
- |
- |
075 1件: 75 💬 |
100 |
Other: control |
- |
- |
- |
- |
006 8件: 6 , 19, 70, 75, 85, 97, 162, 193 💬 |
101 |
Other: hydrocortisone |
Hydrocortisone |
1件: D00088 D00088 💬 |
NR3C1 1件: NR3C1 💬 |
Neuroactive ligand-receptor interaction 1件: Neuroactive ligand-receptor interaction |
075 1件: 75 💬 |
102 |
Other: obese |
- |
- |
- |
- |
075 1件: 75 💬 |
103 |
Ovine corticotropin-releasing hormone (ocrh) |
Corticorelin |
2件: D00146 D00146, D03905 D03905 💬 |
CRHR1 3件: CRHR1, CRHR2, MC2R 💬 |
Aldosterone synthesis and secretion 6件: Aldosterone synthesis and secretion, Cortisol synthesis and secretion, Cushing syndrome, Long-term depression, Neuroactive ligand-receptor interaction, cAMP signaling pathway |
075 1件: 75 💬 |
104 |
Pasireotida |
Pasireotide |
1件: D10147 D10147 💬 |
SSTR1 4件: SSTR1, SSTR2, SSTR3, SSTR5 💬 |
Gastric acid secretion 4件: Gastric acid secretion, Growth hormone synthesis, secretion and action, Neuroactive ligand-receptor interaction, cAMP signaling pathway |
075 1件: 75 💬 |
105 |
Pasireotida 300 |
Pasireotide |
1件: D10147 D10147 💬 |
SSTR1 4件: SSTR1, SSTR2, SSTR3, SSTR5 💬 |
Gastric acid secretion 4件: Gastric acid secretion, Growth hormone synthesis, secretion and action, Neuroactive ligand-receptor interaction, cAMP signaling pathway |
075 1件: 75 💬 |
106 |
Pasireotida 600 |
Pasireotide |
1件: D10147 D10147 💬 |
SSTR1 4件: SSTR1, SSTR2, SSTR3, SSTR5 💬 |
Gastric acid secretion 4件: Gastric acid secretion, Growth hormone synthesis, secretion and action, Neuroactive ligand-receptor interaction, cAMP signaling pathway |
075 1件: 75 💬 |
107 |
Pasireotida 900 |
Pasireotide |
1件: D10147 D10147 💬 |
SSTR1 4件: SSTR1, SSTR2, SSTR3, SSTR5 💬 |
Gastric acid secretion 4件: Gastric acid secretion, Growth hormone synthesis, secretion and action, Neuroactive ligand-receptor interaction, cAMP signaling pathway |
075 1件: 75 💬 |
108 |
Pasireotide |
Pasireotide |
1件: D10147 D10147 💬 |
SSTR1 4件: SSTR1, SSTR2, SSTR3, SSTR5 💬 |
Gastric acid secretion 4件: Gastric acid secretion, Growth hormone synthesis, secretion and action, Neuroactive ligand-receptor interaction, cAMP signaling pathway |
067 3件: 67, 74, 75 💬 |
109 |
Pasireotide 0.3mg |
Pasireotide |
1件: D10147 D10147 💬 |
SSTR1 4件: SSTR1, SSTR2, SSTR3, SSTR5 💬 |
Gastric acid secretion 4件: Gastric acid secretion, Growth hormone synthesis, secretion and action, Neuroactive ligand-receptor interaction, cAMP signaling pathway |
075 1件: 75 💬 |
110 |
Pasireotide 0.6 mg/ml |
Pasireotide |
1件: D10147 D10147 💬 |
SSTR1 4件: SSTR1, SSTR2, SSTR3, SSTR5 💬 |
Gastric acid secretion 4件: Gastric acid secretion, Growth hormone synthesis, secretion and action, Neuroactive ligand-receptor interaction, cAMP signaling pathway |
075 1件: 75 💬 |
111 |
Pasireotide 0.6mg |
Pasireotide |
1件: D10147 D10147 💬 |
SSTR1 4件: SSTR1, SSTR2, SSTR3, SSTR5 💬 |
Gastric acid secretion 4件: Gastric acid secretion, Growth hormone synthesis, secretion and action, Neuroactive ligand-receptor interaction, cAMP signaling pathway |
075 1件: 75 💬 |
112 |
Pasireotide 0.9 mg |
Pasireotide |
1件: D10147 D10147 💬 |
SSTR1 4件: SSTR1, SSTR2, SSTR3, SSTR5 💬 |
Gastric acid secretion 4件: Gastric acid secretion, Growth hormone synthesis, secretion and action, Neuroactive ligand-receptor interaction, cAMP signaling pathway |
075 1件: 75 💬 |
113 |
Pasireotide 20mg |
Pasireotide |
1件: D10147 D10147 💬 |
SSTR1 4件: SSTR1, SSTR2, SSTR3, SSTR5 💬 |
Gastric acid secretion 4件: Gastric acid secretion, Growth hormone synthesis, secretion and action, Neuroactive ligand-receptor interaction, cAMP signaling pathway |
075 1件: 75 💬 |
114 |
Pasireotide 40mg |
Pasireotide |
1件: D10147 D10147 💬 |
SSTR1 4件: SSTR1, SSTR2, SSTR3, SSTR5 💬 |
Gastric acid secretion 4件: Gastric acid secretion, Growth hormone synthesis, secretion and action, Neuroactive ligand-receptor interaction, cAMP signaling pathway |
075 1件: 75 💬 |
115 |
Pasireotide 60mg |
Pasireotide |
1件: D10147 D10147 💬 |
SSTR1 4件: SSTR1, SSTR2, SSTR3, SSTR5 💬 |
Gastric acid secretion 4件: Gastric acid secretion, Growth hormone synthesis, secretion and action, Neuroactive ligand-receptor interaction, cAMP signaling pathway |
075 1件: 75 💬 |
116 |
Pasireotide diaspartate |
Pasireotide |
1件: D10147 D10147 💬 |
SSTR1 4件: SSTR1, SSTR2, SSTR3, SSTR5 💬 |
Gastric acid secretion 4件: Gastric acid secretion, Growth hormone synthesis, secretion and action, Neuroactive ligand-receptor interaction, cAMP signaling pathway |
075 1件: 75 💬 |
117 |
Pasireotide lar |
Pasireotide |
1件: D10147 D10147 💬 |
SSTR1 4件: SSTR1, SSTR2, SSTR3, SSTR5 💬 |
Gastric acid secretion 4件: Gastric acid secretion, Growth hormone synthesis, secretion and action, Neuroactive ligand-receptor interaction, cAMP signaling pathway |
067 2件: 67, 75 💬 |
118 |
Pasireotide pamoate |
Pasireotide |
1件: D10147 D10147 💬 |
SSTR1 4件: SSTR1, SSTR2, SSTR3, SSTR5 💬 |
Gastric acid secretion 4件: Gastric acid secretion, Growth hormone synthesis, secretion and action, Neuroactive ligand-receptor interaction, cAMP signaling pathway |
075 1件: 75 💬 |
119 |
Pasireotide s.c. |
Pasireotide |
1件: D10147 D10147 💬 |
SSTR1 4件: SSTR1, SSTR2, SSTR3, SSTR5 💬 |
Gastric acid secretion 4件: Gastric acid secretion, Growth hormone synthesis, secretion and action, Neuroactive ligand-receptor interaction, cAMP signaling pathway |
075 1件: 75 💬 |
120 |
Pasireotide sub-cutaneous |
Pasireotide |
1件: D10147 D10147 💬 |
SSTR1 4件: SSTR1, SSTR2, SSTR3, SSTR5 💬 |
Gastric acid secretion 4件: Gastric acid secretion, Growth hormone synthesis, secretion and action, Neuroactive ligand-receptor interaction, cAMP signaling pathway |
075 1件: 75 💬 |
121 |
Pasireotide with or without cabergoline |
Cabergoline |
2件: D00987 D00987, D10147 D10147 💬 |
DRD2 6件: DRD2, PRL, SSTR1, SSTR2, SSTR3, SSTR5 💬 |
Alcoholism 14件: Alcoholism, Cocaine addiction, Cytokine-cytokine receptor interaction, Dopaminergic synapse, Gap junction, Gastric acid secretion, Growth hormone synthesis, secretion and action, JAK-STAT signaling pathway, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway, Parkinson disease, Prolactin signaling pathway, Rap1 signaling pathway, cAMP signaling pathway |
075 1件: 75 💬 |
122 |
Pasireotode |
- |
- |
- |
- |
075 1件: 75 💬 |
123 |
Pentetreotide |
Pentetreotide |
1件: D01859 D01859 💬 |
- |
- |
075 1件: 75 💬 |
124 |
Phe |
- |
- |
- |
- |
075 2件: 75, 240 💬 |
125 |
Prednisolone |
Prednisolone |
8件: D00472 D00472, D00980 D00980, D00981 D00981, D00982 D00982, D01239 D01239, D01998 D01998, D02156 D02156, D03301 D03301 💬 |
NR3C1 1件: NR3C1 💬 |
Neuroactive ligand-receptor interaction 1件: Neuroactive ligand-receptor interaction |
011 40件: 11, 13, 14, 25, 26, 35, 38, 39, 40, 41, 43, 44, 45, 46, 49, 50, 51, 56, 60, 61, 63, 64, 65, 66, 75, 81, 84, 85, 95, 96, 97, 113, 145, 162, 222, 269, 271, 296, 299, 300 💬 |
126 |
Procedure: hypercortisolism |
- |
- |
- |
- |
075 1件: 75 💬 |
127 |
Procedure: lateral transperitoneal la |
- |
- |
- |
- |
075 1件: 75 💬 |
128 |
Procedure: posterior ra |
- |
- |
- |
- |
075 1件: 75 💬 |
129 |
R-roscovitine |
Seliciclib |
- |
- |
- |
075 1件: 75 💬 |
130 |
Radiation: dotatate pet-ct |
Dotatate |
- |
- |
- |
075 1件: 75 💬 |
131 |
Radiation: f-dopa pet ct |
- |
- |
- |
- |
075 1件: 75 💬 |
132 |
Relacorilant |
Relacorilant |
1件: D11336 D11336 💬 |
NR3C1 1件: NR3C1 💬 |
Neuroactive ligand-receptor interaction 1件: Neuroactive ligand-receptor interaction |
075 1件: 75 💬 |
133 |
Rivaroxaban |
Rivaroxaban |
1件: D07086 D07086 💬 |
F10 1件: F10 💬 |
Complement and coagulation cascades 1件: Complement and coagulation cascades |
046 5件: 46, 49, 75, 91, 210 💬 |
134 |
Rosiglitazone |
Rosiglitazone |
2件: D00596 D00596, D08491 D08491 💬 |
PPARG 1件: PPARG 💬 |
AMPK signaling pathway 9件: AMPK signaling pathway, Huntington disease, Longevity regulating pathway, Osteoclast differentiation, PPAR signaling pathway, Pathways in cancer, Thermogenesis, Thyroid cancer, Transcriptional misregulation in cancer |
046 5件: 46, 75, 97, 222, 265 💬 |
135 |
Rosiglitazone maleate |
Rosiglitazone |
2件: D00596 D00596, D08491 D08491 💬 |
PPARG 1件: PPARG 💬 |
AMPK signaling pathway 9件: AMPK signaling pathway, Huntington disease, Longevity regulating pathway, Osteoclast differentiation, PPAR signaling pathway, Pathways in cancer, Thermogenesis, Thyroid cancer, Transcriptional misregulation in cancer |
046 3件: 46, 75, 265 💬 |
136 |
Rvg 08938 |
- |
- |
- |
- |
075 1件: 75 💬 |
137 |
Rvg 15375 |
- |
- |
- |
- |
075 1件: 75 💬 |
138 |
Rvg 18236 |
- |
- |
- |
- |
075 2件: 75, 227 💬 |
139 |
Seliciclib |
Seliciclib |
- |
- |
- |
075 2件: 75, 299 💬 |
140 |
Signifor |
- |
- |
- |
- |
075 1件: 75 💬 |
141 |
Sitagliptin |
Sitagliptin |
1件: D08516 D08516 💬 |
DPP4 1件: DPP4 💬 |
Protein digestion and absorption 1件: Protein digestion and absorption |
006 4件: 6 , 75, 233, 299 💬 |
142 |
Som230 |
- |
- |
- |
- |
074 2件: 74, 75 💬 |
143 |
Som230 300µg |
- |
- |
- |
- |
075 1件: 75 💬 |
144 |
Som230 600µg |
- |
- |
- |
- |
075 1件: 75 💬 |
145 |
Som230 900µg |
- |
- |
- |
- |
075 1件: 75 💬 |
146 |
Som230 lar |
- |
- |
- |
- |
075 1件: 75 💬 |
147 |
Som230 lar 10 mg |
- |
- |
- |
- |
075 1件: 75 💬 |
148 |
Som230 lar 30 mg |
- |
- |
- |
- |
075 1件: 75 💬 |
149 |
Som230 lar, 20 mg |
- |
- |
- |
- |
075 1件: 75 💬 |
150 |
Som230 s.c. |
- |
- |
- |
- |
075 1件: 75 💬 |
151 |
Som230, 300micrograms |
- |
- |
- |
- |
075 1件: 75 💬 |
152 |
Som230, 600 micrograms |
- |
- |
- |
- |
075 1件: 75 💬 |
153 |
Som230, 900 micrograms |
- |
- |
- |
- |
075 1件: 75 💬 |
154 |
Som230b |
- |
- |
- |
- |
075 1件: 75 💬 |
155 |
Somatropin |
Somatotropin |
1件: D02691 D02691 💬 |
GHR 1件: GHR 💬 |
Cytokine-cytokine receptor interaction 5件: Cytokine-cytokine receptor interaction, Growth hormone synthesis, secretion and action, JAK-STAT signaling pathway, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway |
002 16件: 2 , 3 , 19, 46, 74, 75, 78, 96, 113, 187, 193, 195, 265, 274, 276, 299 💬 |
156 |
Tadalafil |
Tadalafil |
1件: D02008 D02008 💬 |
PDE5A 1件: PDE5A 💬 |
Metabolic pathways 3件: Metabolic pathways, Purine metabolism, cGMP-PKG signaling pathway |
006 7件: 6 , 51, 75, 84, 86, 113, 210 💬 |
157 |
Tretinoin |
Tretinoin |
1件: D00094 D00094 💬 |
PML 3件: PML, RARA, RARB 💬 |
Acute myeloid leukemia 12件: Acute myeloid leukemia, Endocytosis, Estrogen signaling pathway, Gastric cancer, Herpes simplex virus 1 infection, Influenza A, Non-small cell lung cancer, Pathways in cancer, Small cell lung cancer, Th17 cell differentiation, Transcriptional misregulation in cancer, Ubiquitin mediated proteolysis |
002 2件: 2 , 75 💬 |
158 |
Trp |
- |
- |
- |
- |
075 1件: 75 💬 |
159 |
Tyr |
- |
- |
- |
- |
075 2件: 75, 298 💬 |
160 |
Valsartan |
Valsartan |
1件: D00400 D00400 💬 |
AGTR1 1件: AGTR1 💬 |
AGE-RAGE signaling pathway in diabetic complications 16件: AGE-RAGE signaling pathway in diabetic complications, Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Apelin signaling pathway, Calcium signaling pathway, Coronavirus disease - COVID-19, Cortisol synthesis and secretion, Cushing syndrome, Diabetic cardiomyopathy, Neuroactive ligand-receptor interaction, Pathways in cancer, Phospholipase D signaling pathway, Renin secretion, Renin-angiotensin system, Vascular smooth muscle contraction, cGMP-PKG signaling pathway |
057 7件: 57, 58, 66, 75, 218, 222, 224 💬 |
161 |
Vorinostat |
Vorinostat |
1件: D06320 D06320 💬 |
HDAC1 11件: HDAC1, HDAC10, HDAC11, HDAC2, HDAC3, HDAC4, HDAC5, HDAC6, HDAC7, HDAC8, HDAC9 💬 |
Alcoholism 17件: Alcoholism, Amphetamine addiction, Amyotrophic lateral sclerosis, Apelin signaling pathway, Cell cycle, Chronic myeloid leukemia, Epstein-Barr virus infection, Human papillomavirus infection, Huntington disease, Longevity regulating pathway - multiple species, MicroRNAs in cancer, Neutrophil extracellular trap formation, Notch signaling pathway, Pathways in cancer, Thyroid hormone signaling pathway, Transcriptional misregulation in cancer, Viral carcinogenesis |
019 3件: 19, 75, 96 💬 |